Unlock instant, AI-driven research and patent intelligence for your innovation.

Bile acid compounds, intermediates, preparation methods and applications thereof

A compound and bile acid technology, applied in the direction of steroids, organic chemistry, radioactive carriers, etc., can solve the problems of unsuitable diagnosis of liver cancer cells and low sensitivity

Active Publication Date: 2015-08-12
上海深景医药科技有限公司
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The technical problem to be solved by the present invention is to overcome the existing 18 F radiolabeled compounds are not suitable for the diagnosis of liver cancer cells, and the defects of low sensitivity provide a bile acid compound, especially 18 F-labeled bile acid compounds, intermediates, preparation methods and applications thereof

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Bile acid compounds, intermediates, preparation methods and applications thereof
  • Bile acid compounds, intermediates, preparation methods and applications thereof
  • Bile acid compounds, intermediates, preparation methods and applications thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0213] Synthesis of labeled precursor compounds

[0214] [Example 1] Synthesis of chenodeoxycholyl propargylamine (B3)

[0215] Chenodeoxycholic acid 393mg (1mmol) was added to 30mL CH 2 Cl 2 230 mg (1.2 mmol) of EDC.HCl, 162 mg (1.2 mmol) of HOBt, 280 μL (2 mmol) of triethylamine were added under stirring, and 82.5 μL (1.2 mmol) of propargylamine was added after stirring for several minutes. The above reaction solution was stirred and reacted at room temperature for two days. The reaction solution was washed once with water, once with saturated sodium bicarbonate solution, once with dilute hydrochloric acid, and twice with saturated sodium chloride solution. After the organic layer was dried over anhydrous sodium sulfate, it was purified by column chromatography (developing solvent: petroleum ether, ethyl acetate ). 315.6 mg of white solid was obtained. Yield 73.5%, purity 99% (HPLC).

[0216] The identification data of B3 are as follows: TOF-ESI-MS: M(C 27 h 43 NO 3...

Embodiment 2

[0234] Synthesis of reference compounds

example 1

[0235] [Example 1], the synthesis of the reference compound A'3-B corresponding to A3-B

[0236] Under magnetic stirring, add 170 μL of copper sulfate solution (0.45 mol / L) and 100 μL of sodium ascorbate solution (1.5 mol / L) to 2 mL of pH=6.0 phosphate buffer, mix well and add B3 (25 μmol, 11 mg) in DMF Solution (500 μL), after 10 minutes, add 2-azido-1-fluoroethane in acetonitrile solution (125 μmol, V=3mL), and stir at 50°C for 3 hours. After cooling to room temperature, the reaction solution was diluted with 30 mL of water, and the product was extracted three times with chloroform (15 mL each time). The organic layers were combined, washed with 15 mL of saturated sodium chloride solution, and concentrated under reduced pressure to obtain the product as a white solid. Mass: 11.2 mg, yield: 86.5%, purity 99% (HPLC).

[0237] The identification data of A'3-B are as follows: TOF-ESI-MS: M(C 29 h 47 FN 4 o 3 )=518.71(m / z),519.5[M+H] + ,541.4[M+Na] + .

[0238] 1 H-NMR ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a bile acid type compound, an intermediate, a preparation method and an application of the bile acid type compound. The invention provides a bile acid type compound as shown in a formula A. When the 18F-labeled bile acid type compound A is applied as a positron emission tomography imaging agent, the great in-vivo and in-vitro stability is realized; when PET (positron emission tomography) imaging is performed, defluorination imaging is invisible; and furthermore, the bile acid type compound has the advantages of relatively fast in-vivo clearance speed and huge application potentials in research of liver function imaging, physiology and pathology, as well as diagnosis of diseases of a digestive system, in particular to the diagnosis of liver cancer and colon cancer.

Description

technical field [0001] The invention relates to the field of radiographic imaging, in particular to a bile acid compound, an intermediate and a preparation method and application thereof. Background technique [0002] Primary liver cancer (referred to as liver cancer) ranks fifth in cancer incidence and third in mortality worldwide. In my country, the annual mortality rate of liver cancer accounts for the second place in tumor mortality (Siegel AB, Cohen EI, Ocean A, et al. Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma. J Clin Oncol. 2008; 26:2992-2998). The histological types of liver cancer include hepatocellular carcinoma (91.5%), cholangiocarcinoma and mixed liver cancer (Li Linfa, Zhang Minming, etc. Tumor Targeted Molecular Imaging. Beijing: Science Press, 2006, 246-247). The onset of liver cancer is relatively insidious, and there is no specific clinical manifestation in the early stage. Most patie...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07J43/00C07J41/00A61K51/04A61K101/02
Inventor 张岚贾丽娜程登峰江大卫石洪成
Owner 上海深景医药科技有限公司